Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Marker Therapeutics Q2 EPS $0.29 Up From $(1.10) YoY, Sales $762.66K Down From $790.51K YoY

Author: Benzinga Newsdesk | August 14, 2023 04:57pm
Marker Therapeutics (NASDAQ:MRKR) reported quarterly earnings of $0.29 per share. This is a 126.36 percent increase over losses of $(1.10) per share from the same period last year. The company reported $762.66 thousand in sales this quarter. This is a 3.52 percent decrease over sales of $790.51 thousand the same period last year.

Posted In: MRKR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist